Akito Natsume to Antineoplastic Agents
This is a "connection" page, showing publications Akito Natsume has written about Antineoplastic Agents.
Connection Strength
0.177
-
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity. Cancer Sci. 2009 Dec; 100(12):2411-8.
Score: 0.141
-
Nonfucosylated anti-CD20 antibody potentially induces apoptosis in lymphoma cells through enhanced interaction with FcgammaRIIIb on neutrophils. Leuk Res. 2010 May; 34(5):666-71.
Score: 0.037